Kyla Miller Foundation

Joining in the fight to end pediatric brain cancer...
P.O. Box 712     Dillsburg, Pennsylvania  17019
(717) 259-9742     info@kylamillerfoundation.org 

          Advocacy
Kyla Miller Foundation does not lobby any branch of the United States federal, state and local government for changes in legislation.  Our purpose is to raise money to fund pediatric brain cancer research.  Through our efforts we hope to raise awareness to the public of this devastating disease by engaging in informational and fundraising events in the hope for a better future for children everywhere with brain and spinal cord tumors.

We will make every attempt to post potential legislation on this site to better inform you of what the United States government is doing on their part to help in this battle.
 

          Avastin Approved to Treat Glioblastoma Multiforme
The Food and Drug Administration has granted fast-track approval for Avastin to be used to treat glioblastoma multiforme.  Still today, this aggressive type of brain cancer still has no cure.  However, Avastin has shown to have some positive effects with stemming the speed of which this type of tumor grows while minimizing the impact to the patient.  Long-term studies are still underway and will take time to prove or disprove that Avastin is a viable option to prolonging life for patients with glioblastoma multiforme.
 
Current Legislation
HR 653 / S.305: The National Childhood Brain Tumor Prevention Network Act
HR971 - 10-10-10 Pediatric Brain Tumor Awareness Day in Pennsylvania
     

Kyla Miller Foundation is a Pennsylvania state registered non-profit organization joining in the fight to end pediatric brain cancer. KMF is named lovingly after
Kyla LeeAnne Miller, a loving and vibrant child who succumbed to glioblastoma multiforme just two days shy of her tenth birthday. 
Copyright 2008 - 2011 Kyla Miller Foundation.  All rights reserved.  This site hosted by Stamm Solutions.